[go: up one dir, main page]

DE69717664D1 - Protein e25a, methoden zu dessen herstellung und anwendung - Google Patents

Protein e25a, methoden zu dessen herstellung und anwendung

Info

Publication number
DE69717664D1
DE69717664D1 DE69717664T DE69717664T DE69717664D1 DE 69717664 D1 DE69717664 D1 DE 69717664D1 DE 69717664 T DE69717664 T DE 69717664T DE 69717664 T DE69717664 T DE 69717664T DE 69717664 D1 DE69717664 D1 DE 69717664D1
Authority
DE
Germany
Prior art keywords
protein
cancer
nucleic acid
refractory prostate
hormone refractory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69717664T
Other languages
English (en)
Inventor
Robert E Reiter
Owen N Witte
Charles L Sawyers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
University of California Berkeley
Original Assignee
University of California
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California Berkeley filed Critical University of California
Application granted granted Critical
Publication of DE69717664D1 publication Critical patent/DE69717664D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69717664T 1996-09-06 1997-09-05 Protein e25a, methoden zu dessen herstellung und anwendung Expired - Lifetime DE69717664D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2556996P 1996-09-06 1996-09-06
PCT/US1997/015606 WO1998010069A2 (en) 1996-09-06 1997-09-05 E25a PROTEIN, METHODS FOR PRODUCTION AND USE THEREOF

Publications (1)

Publication Number Publication Date
DE69717664D1 true DE69717664D1 (de) 2003-01-16

Family

ID=21826823

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69717664T Expired - Lifetime DE69717664D1 (de) 1996-09-06 1997-09-05 Protein e25a, methoden zu dessen herstellung und anwendung

Country Status (7)

Country Link
US (2) US6093800A (de)
EP (1) EP0942972B1 (de)
AT (1) ATE229073T1 (de)
AU (1) AU4181897A (de)
CA (1) CA2265889A1 (de)
DE (1) DE69717664D1 (de)
WO (1) WO1998010069A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935805B1 (en) * 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
WO2000039302A2 (en) * 1998-12-31 2000-07-06 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
WO2000039303A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Modified hiv env polypeptides
CA2358385C (en) 1998-12-31 2013-08-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
ATE478952T1 (de) 1999-10-28 2010-09-15 Agensys Inc 36p6d5: ausgeschiedenes tumorprotein
US20020155514A1 (en) * 2000-12-01 2002-10-24 Hale Laura P. Zinc alpha-2-glycoprotein as indicator of cancer
AU2002245108A1 (en) * 2000-12-15 2002-07-30 Origene Technologies, Inc. Angiogenesis gene and modulators
EP1573022B1 (de) * 2001-04-10 2011-06-08 Agensys, Inc. Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
CA2452119C (en) * 2001-07-05 2013-10-15 Chiron Corporation Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof
WO2003020876A2 (en) * 2001-08-31 2003-03-13 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US20030170614A1 (en) * 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US8507445B2 (en) * 2001-09-07 2013-08-13 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US7671010B2 (en) * 2002-08-30 2010-03-02 The Board Of Regents Of The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
CA2496938A1 (en) * 2002-08-30 2004-03-11 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
SI2484375T1 (en) 2006-09-26 2018-08-31 Infectious Disease Research Institute A vaccine composition comprising a synthetic adjuvant
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US20100129361A1 (en) * 2007-05-01 2010-05-27 The Brigham And Women's Hospital Immunosuppression with antibody against itm2a
HRP20161585T1 (hr) 2009-06-05 2016-12-30 Infectious Disease Research Institute Sintetski glukopiranozilni lipidi kao adjuvansi i cjepivni pripravci koji ih sadrže
CA2832307A1 (en) 2011-04-08 2012-10-18 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
EP2811981B1 (de) 2012-02-07 2019-05-08 Infectious Disease Research Institute Verbesserte hilfsstoffformulierungen mit tlr4-agonisten und verwendungsverfahren dafür
ES2673556T3 (es) 2012-05-16 2018-06-22 Immune Design Corp. Vacunas para el VHS-2
EP3711768A1 (de) 2013-04-18 2020-09-23 Immune Design Corp. Gla-monotherapie zur verwendung in der krebsbehandlung
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
JP6741580B2 (ja) 2013-12-31 2020-08-19 インフェクシャス ディズィーズ リサーチ インスティチュート 単一バイアルのワクチン製剤
RU2753874C2 (ru) 2016-06-01 2021-08-24 Инфекшес Дизис Рисёрч Инститьют Наноалюмочастицы, содержащие агент, регулирующий размер
CN111315406A (zh) 2017-09-08 2020-06-19 传染病研究所 包括皂苷的脂质体调配物及其使用方法
MX2021014363A (es) 2019-05-25 2022-02-21 Infectious Disease Res Inst Composicion y metodo para secar por pulverizacion una emulsion de vacuna adyuvante.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4204642B2 (ja) * 1992-11-05 2009-01-07 スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ 前立腺に特異的な膜抗原

Also Published As

Publication number Publication date
ATE229073T1 (de) 2002-12-15
EP0942972B1 (de) 2002-12-04
EP0942972A2 (de) 1999-09-22
WO1998010069A2 (en) 1998-03-12
US6093800A (en) 2000-07-25
CA2265889A1 (en) 1998-03-12
WO1998010069A3 (en) 1998-05-07
US7030232B1 (en) 2006-04-18
AU4181897A (en) 1998-03-26

Similar Documents

Publication Publication Date Title
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
ES2317704T3 (es) Un nuevo metodo para el diagnostico, seguimiento, estadificacion. imagineria y tratamiento de distintos canceres.
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
DE69926630D1 (de) Antikörper gegen die ed-b domäne von fibronektin, solche antikörper enthaltende konjugate, und deren verwendung zur diagnose und therapie von angiogenese-assoziierten tumoren und krankheiten
ATE345399T1 (de) Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
ATE396266T1 (de) Trp8 krebsmarker
WO2004110345A3 (en) Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
WO2004092338A3 (en) Compositions, splice variants and methods relating to cancer specific genes and proteins
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE69837529D1 (de) Proteinmarker für lungenkrebs und deren verwendung
DE60028830D1 (de) Anti-april antikörper und hybridomazellen
DE69231245D1 (de) Veraendertes gen bei menschlichem colorektalem-krebs
AR026946A1 (es) Osteoprotegerina/receptores de factores de necrosis de tumores
EP2263679A3 (de) Auf Proteine in Verbindung mit Krebs zielende RNAi-Sonde
WO2002062945A3 (en) Compositions and methods relating to lung specific genes and proteins
ATE350662T1 (de) Markerproteine für prostatakrebs
WO2002031209A3 (en) Genes related to development of refractory prostate cancer
WO2003105773A3 (en) Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets:
EP1377596A4 (de) Ttk in der diagnose und als therapeutisches target bei krebs
ATE152629T1 (de) Diagnose von krebs-metastasen durch das mts-1 gen
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
DE60221115D1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
WO2004040312A3 (fr) Proceded de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie
DE69636041D1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen

Legal Events

Date Code Title Description
8332 No legal effect for de